Sequence Bio Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 31
Employees
  • Latest Deal Type
  • Accelerator/​Inc
  • Latest Deal Amount
  • $150K
Latest Deal Amount
  • Investors
  • 9

Sequence Bio General Information

Description

Developer of a genome therapy designed to discover enhanced medicines and improve the treatment of a disease. The company's therapy is collaborated through the gathering of DNA and health information of unique isolated populations and is used to treat complex and inherited diseases, enabling healthcare providers to improve the lives of the patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 53 Bond Street
  • Suite 100
  • Saint John's, Newfoundland and Labrador A1C 1S9
  • Canada
+1 (800) 000-0000

Sequence Bio Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sequence Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator 21-Aug-2019 $150K 00.000 Completed Generating Revenue
4. Later Stage VC 30-Jul-2019 00.000 00.000 Completed Generating Revenue
3. Seed Round 03-Aug-2016 00.00 00.00 Completed Generating Revenue
2. Seed Round 19-Oct-2015 $1M $1M Completed Generating Revenue
1. Accelerator/Incubator 01-Aug-2015 Completed Generating Revenue
To view Sequence Bio’s complete valuation and funding history, request access »

Sequence Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a genome therapy designed to discover enhanced medicines and improve the treatment of a disease. The compan
Biotechnology
Saint John's, Canada
31 As of 2021
00.000
000000000000 00.000

00000000

ute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Exc
0000 000000000
New York, NY
00 As of 0000
0000
00.00 0000-00-00
00000000000 0000

000 0000

t amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliq
0000 000000000
Barcelona, Spain
00 As of 0000
0000
00000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sequence Bio Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Volastra Venture Capital-Backed New York, NY 00 0000 00000000000 0000
000 000000000000 Venture Capital-Backed Barcelona, Spain 00 0000 00000000000 0000
00 000000000000 Formerly VC-backed Durham, NC 000 00000 000000 - 000 00000
0000000 000000 Venture Capital-Backed Barcelona, Spain 00 0000 000000000000 0000
0000000 000000 Venture Capital-Backed Stockholm, Sweden 0 000.00 0000000000 0 000.00
You’re viewing 5 of 7 competitors. Get the full list »

Sequence Bio Executive Team (12)

Name Title Board Seat Contact Info
Chris Gardner Co-Founder, Chief Executive Officer, President & Board Member
Lynn Healey Chief Financial Officer
Michael Phillips Ph.D Chief Scientific Officer
Dave Phillips Director of Finance & Administration
Will Ferguson Senior Vice President, Business Development
You’re viewing 5 of 12 executive team members. Get the full list »

Sequence Bio Board Members (6)

Name Representing Role Since
Andrew Furey Sequence Bio Board Member 000 0000
Chris Gardner Sequence Bio Co-Founder, Chief Executive Officer, President & Board Member 000 0000
Chris Moyer Pelorus Venture Capital Board Member 000 0000
James Hardiman DCVC Board Member 000 0000
Mark Dobbin Killick Capital Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Sequence Bio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sequence Bio Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Y Combinator Accelerator/Incubator 000 0000 000000 0
C3 Ventures (VC) Venture Capital Minority 000 0000 000000 0
BDC Capital IT Venture Fund Venture Capital Minority 000 0000 000000 0
DCVC Venture Capital Minority 000 0000 000000 0
Killick Capital PE/Buyout Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »